Avadel Pharmaceuticals (AVDL) Q3 2023 Earnings

8NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.66
-0.44
-0.22
0

Details

Expected EPS
-0.37
Actual EPS
-0.41
Surprise EPS
-0.04
Surprise Percent
+10.81%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of -0.41 per share for Q3 2023.

0 Comments

Share your thoughts